Corona Remedies

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,501.10
43.9 (3.01%)
BSENSE

Feb 03

BSE+NSE Vol: 75.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Alivus Life
Sanofi India
Viyash Scientifi
Strides Pharma
Blue Jet Health
Marksans Pharma
Sanofi Consumer
P & G Health Ltd
Concord Biotech
Corona Remedies
Rubicon Research
Why is Corona Remedies Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.86
Tax Ratio
24.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.60%
ROCE (avg)
29.97%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
62
Industry P/E
32
Price to Book Value
15.16
EV to EBIT
45.23
EV to EBITDA
38.23
EV to Capital Employed
15.31
EV to Sales
7.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.85%
ROE (Latest)
24.61%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Icon
No Data found
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
PBDIT(Q)

Highest at Rs 83.16 cr.

PBT LESS OI(Q)

Highest at Rs 72.05 cr.

PAT(Q)

Highest at Rs 55.53 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 24.29%

-1What is not working for the Company
EPS(Q)

Lowest at Rs 6.74

Loading Valuation Snapshot...
Here's what is working for Corona Remedies
Operating Profit (PBDIT) - Quarterly
Highest at Rs 83.16 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 72.05 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 55.53 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 24.29%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 72.05 cr has Grown at 20.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 59.61 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Corona Remedies
Earnings per Share (EPS) - Quarterly
Lowest at Rs 6.74
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)